Hemoptysis News and Research

RSS
Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers